CD79b targeting ADC with superior pharmacokinetic profile and anti-tumor activity.

被引：0

作者：

Spycher, Philipp Rene ^{[1
]}

Probst, Philipp ^{[1
]}

Bertrand, Romain ^{[1
]}

Stark, Ramona ^{[1
]}

Santimaria, Roger ^{[1
]}

Grabulovski, Dragan ^{[1
]}

Attinger-Toller, Isabella ^{[1
]}

机构：

[1] Araris Biotech AG, Zurich, Switzerland

来源：

CANCER RESEARCH | 2021年 / 81卷 / 13期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1842

引用

页数：1

共 50 条

[41] Natural polysaccharides exhibit anti-tumor activity by targeting gut microbiota [J].

Liu, Liqiao ;

Li, Mingzhu ;

Yu, Mulan ;

Shen, Mingyue ;

Wang, Qun ;

Yu, Yue ;

Xie, Jianhua .

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2019, 121 :743-751

[42] Advances in Anti-Tumor Treatments Targeting the CD47/SIRPα Axis [J].

Zhang, Wenting ;

Huang, Qinghua ;

Xiao, Weiwei ;

Zhao, Yue ;

Pi, Jiang ;

Xu, Huan ;

Zhao, Hongxia ;

Xu, Junfa ;

Evans, Colin E. ;

Jin, Hua .

FRONTIERS IN IMMUNOLOGY, 2020, 11

[43] Synthesis and anti-tumor activity of asiatic acid derivatives targeting VEGFR [J].

Meng, Yan-Qiu ;

Wang, Zhi-Qi ;

Li, Jin-Ming ;

Xu, Dong-Ping ;

Meng, Bei-Bei ;

Huang, Mei-Qi .

JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH, 2023, 25 (12) :1205-1216

[44] Targeting tumor metabolism to augment CD8+T cell anti-tumor immunity [J].

Liu, Huan ;

Yang, Wenyong ;

Jiang, Jingwen .

JOURNAL OF PHARMACEUTICAL ANALYSIS, 2025, 15 (05)

[45] Dissecting the mechanism of action targeting TNFR2 with a lignd blocking anti-TNFR2 antibody that elicits potent anti-tumor activity. [J].

Zhao, Xiaofeng ;

Liu, Xiaoqing ;

Gao, Zhenna ;

Wang, Mengyu ;

Li, Wenjing ;

Pang, Ran ;

Yang, Wenqing ;

Cao, Zhuoxiao ;

Tang, Renhong .

CANCER RESEARCH, 2021, 81 (13)

[46] SGN-CD30C, a new CD30-directed camptothecin antibody-drug conjugate (ADC), shows strong anti-tumor activity and superior tolerability in preclinical studies [J].

Ryan, Maureen ;

Lyski, Ryan ;

Bou, Lauren ;

Meyer, David ;

Jin, Steven ;

Simmons, Jessica ;

Benjamin, Dennis ;

Senter, Peter ;

Jeffrey, Scott .

CANCER RESEARCH, 2020, 80 (16)

[47] TREATMENT OF ANTI-SIRPa IN COMBINATION WITH ANTI-TAA EXERTS SUPERIOR ANTI-TUMOR ACTIVITY [J].

Niu, Xiaofeng ;

Wang, Chunnian ;

Zhao, Jinfeng ;

Wang, Haiying ;

Zhang, Li ;

Hu, Jiahui ;

Yu, Jingfeng ;

Lu, Yefeng ;

Guo, Xiaoli ;

Jiang, Haixia ;

Gao, Rui ;

Wu, Zhihao ;

Qiu, Yangsheng ;

Qiu, Quan ;

Song, Zheng ;

Sun, Dawei ;

Lu, Hongtao .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 :A826-A826

[48] LNAplus™ antisense oligonucleotides targeting CD39 and CD73 have potent anti-tumor activity by modulating immunosuppressive tumor microenvironment [J].

Festag, Julia ;

Thelemann, Tamara ;

Kashyap, Abhishek S. ;

Klar, Richard ;

Kallert, Sandra ;

Buchi, Melanie ;

Hinterwimmer, Lisa ;

Schell, Monika ;

Raith, Stefanie ;

Michel, Sven ;

Zippelius, Alfred ;

Jaschinski, Frank .

CANCER RESEARCH, 2019, 79 (13)

[49] TRPH-222, a novel anti-CD22 antibody drug conjugate (ADC), has significant anti-tumor activity in NHL xenografts and reduces B cells in monkeys [J].

Maclaren, Ann P. ;

Levin, Nancy ;

Lowman, Henry .

CANCER RESEARCH, 2018, 78 (13)

[50] RESET: A TCR-coupled antigen receptor with superior targeting sensitivity and reversible drug-regulated anti-tumor activity [J].

Leleux, Jardin ;

Rosenberg, Jillian ;

Sonzogni, Olmo ;

Walker, Rebecca L. ;

Venkitaraman, Anita ;

Garrison, Sarah M. ;

Jin, Nan ;

Gregory, Philip D. ;

Jarjour, Jordan .

MOLECULAR THERAPY, 2025, 33 (04) :1608-1620

← 1 2 3 4 5 →